• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重组猪轮状病毒 VP4 和 VP4-LTB 在干酪乳杆菌中的表达诱导小鼠黏膜和系统抗体应答。

Recombinant porcine rotavirus VP4 and VP4-LTB expressed in Lactobacillus casei induced mucosal and systemic antibody responses in mice.

机构信息

Department of Preventive Veterinary, College of Veterinary, Northeast Agricultural University, 59 Mucai Street, Harbin, PR China.

出版信息

BMC Microbiol. 2009 Dec 4;9:249. doi: 10.1186/1471-2180-9-249.

DOI:10.1186/1471-2180-9-249
PMID:19958557
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2797526/
Abstract

BACKGROUND

Porcine rotavirus infection is a significant cause of morbidity and mortality in the swine industry necessitating the development of effective vaccines for the prevention of infection. Immune responses associated with protection are primarily mucosal in nature and induction of mucosal immunity is important for preventing porcine rotavirus infection.

RESULTS

Lactobacillus casei expressing the major protective antigen VP4 of porcine rotavirus (pPG612.1-VP4) or VP4-LTB (heat-labile toxin B subunit from Echerichia coli) (pPG612.1-VP4-LTB) fusion protein was used to immunize mice orally. The expression of recombinant pPG612.1-VP4 and pPG612.1-VP4-LTB was confirmed by SDS-PAGE and Western blot analysis and surface-displayed expression on L. casei was verified by immunofluorescence. Mice orally immunized with recombinant protein-expressing L. casei produced high levels of serum immunoglobulin G (IgG) and mucosal IgA. The IgA titers from mice immunized with pPG612.1-VP4-LTB were higher than titters from pPG612.1-VP4-immunized mice. The induced antibodies demonstrated neutralizing effects on RV infection.

CONCLUSION

These results demonstrated that VP4 administered in the context of an L. casei expression system is an effective method for stimulating mucosal immunity and that LTB served to further stimulate mucosal immunity suggesting that this strategy can be adapted for use in pigs.

摘要

背景

猪轮状病毒感染是猪养殖业中发病率和死亡率的重要原因,因此需要开发有效的疫苗来预防感染。与保护相关的免疫反应主要是黏膜性的,诱导黏膜免疫对于预防猪轮状病毒感染很重要。

结果

鼠李糖乳杆菌表达猪轮状病毒的主要保护性抗原 VP4(pPG612.1-VP4)或 VP4-LTB(来自大肠杆菌的不耐热毒素 B 亚单位)(pPG612.1-VP4-LTB)融合蛋白,通过口服免疫小鼠。重组 pPG612.1-VP4 和 pPG612.1-VP4-LTB 的表达通过 SDS-PAGE 和 Western blot 分析进行确认,鼠李糖乳杆菌表面展示的表达通过免疫荧光进行验证。用表达重组蛋白的鼠李糖乳杆菌口服免疫的小鼠产生高水平的血清免疫球蛋白 G(IgG)和黏膜 IgA。用 pPG612.1-VP4-LTB 免疫的小鼠的 IgA 滴度高于用 pPG612.1-VP4 免疫的小鼠的滴度。诱导的抗体对 RV 感染具有中和作用。

结论

这些结果表明,在鼠李糖乳杆菌表达系统中给予 VP4 是刺激黏膜免疫的有效方法,而 LTB 进一步刺激了黏膜免疫,表明该策略可适应于猪。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/241e/2797526/01f83335b59e/1471-2180-9-249-8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/241e/2797526/49d13484451c/1471-2180-9-249-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/241e/2797526/3f376f419224/1471-2180-9-249-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/241e/2797526/329cbcf8cb40/1471-2180-9-249-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/241e/2797526/5e5092743a5e/1471-2180-9-249-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/241e/2797526/67cb3abfa79b/1471-2180-9-249-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/241e/2797526/c077bc78a49a/1471-2180-9-249-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/241e/2797526/0f0dc5e08530/1471-2180-9-249-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/241e/2797526/01f83335b59e/1471-2180-9-249-8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/241e/2797526/49d13484451c/1471-2180-9-249-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/241e/2797526/3f376f419224/1471-2180-9-249-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/241e/2797526/329cbcf8cb40/1471-2180-9-249-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/241e/2797526/5e5092743a5e/1471-2180-9-249-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/241e/2797526/67cb3abfa79b/1471-2180-9-249-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/241e/2797526/c077bc78a49a/1471-2180-9-249-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/241e/2797526/0f0dc5e08530/1471-2180-9-249-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/241e/2797526/01f83335b59e/1471-2180-9-249-8.jpg

相似文献

1
Recombinant porcine rotavirus VP4 and VP4-LTB expressed in Lactobacillus casei induced mucosal and systemic antibody responses in mice.重组猪轮状病毒 VP4 和 VP4-LTB 在干酪乳杆菌中的表达诱导小鼠黏膜和系统抗体应答。
BMC Microbiol. 2009 Dec 4;9:249. doi: 10.1186/1471-2180-9-249.
2
Comparison of the immune responses induced by oral immunization of mice with Lactobacillus casei-expressing porcine parvovirus VP2 and VP2 fused to Escherichia coli heat-labile enterotoxin B subunit protein.比较经口免疫表达猪细小病毒 VP2 的干酪乳杆菌和 VP2 融合大肠杆菌不耐热肠毒素 B 亚单位蛋白诱导小鼠免疫应答的效果。
Comp Immunol Microbiol Infect Dis. 2011 Jan;34(1):73-81. doi: 10.1016/j.cimid.2010.02.004. Epub 2010 Mar 11.
3
Oral Immunization with Expressing the Porcine Circovirus Type 2 Cap and LTB Induces Mucosal and Systemic Antibody Responses in Mice.猪圆环病毒 2 型 Cap 和 LTB 表达的口服免疫可诱导小鼠黏膜和系统抗体反应。
Viruses. 2021 Jul 5;13(7):1302. doi: 10.3390/v13071302.
4
Immunogenicity of recombinant Lactobacillus casei-expressing F4 (K88) fimbrial adhesin FaeG in conjunction with a heat-labile enterotoxin A (LTAK63) and heat-labile enterotoxin B (LTB) of enterotoxigenic Escherichia coli as an oral adjuvant in mice.表达F4(K88)菌毛黏附素FaeG的重组干酪乳杆菌与产肠毒素大肠杆菌的热不稳定肠毒素A(LTAK63)和热不稳定肠毒素B(LTB)联合作为口服佐剂在小鼠中的免疫原性。
J Appl Microbiol. 2017 Feb;122(2):506-515. doi: 10.1111/jam.13352. Epub 2016 Dec 12.
5
Oral vaccination with the porcine rotavirus VP4 outer capsid protein expressed by Lactococcus lactis induces specific antibody production.用乳酸乳球菌表达的猪轮状病毒VP4外衣壳蛋白进行口服疫苗接种可诱导特异性抗体产生。
J Biomed Biotechnol. 2010;2010:708460. doi: 10.1155/2010/708460. Epub 2010 Jun 6.
6
Immunization with recombinant Lactobacillus casei strains producing K99, K88 fimbrial protein protects mice against enterotoxigenic Escherichia coli.用产生 K99、K88 菌毛蛋白的重组干酪乳杆菌菌株免疫可保护小鼠免受肠产毒型大肠杆菌感染。
Vaccine. 2012 May 9;30(22):3339-49. doi: 10.1016/j.vaccine.2011.08.036. Epub 2011 Aug 19.
7
Escherichia coli LTB26 mutant enhances immune responses to rotavirus antigen VP8 in a mouse model.大肠杆菌 LTB26 突变体能增强轮状病毒抗原 VP8 在小鼠模型中的免疫应答。
Mol Immunol. 2024 Sep;173:10-19. doi: 10.1016/j.molimm.2024.07.001. Epub 2024 Jul 14.
8
Protection against rotavirus shedding after intranasal immunization of mice with a chimeric VP6 protein does not require intestinal IgA.用嵌合VP6蛋白经鼻免疫小鼠后,对轮状病毒脱落的保护作用并不需要肠道IgA。
Virology. 2006 Mar 15;346(2):338-47. doi: 10.1016/j.virol.2005.11.016. Epub 2006 Jan 10.
9
[Enterotoxigenic Escherichia coli heat-labile enterotoxin B subunit can efficiently induce and enhance the mucosal immune response to enterovirus 71].产肠毒素大肠杆菌热不稳定肠毒素B亚基可有效诱导并增强针对肠道病毒71型的黏膜免疫反应
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014 Dec;30(12):1233-7.
10
Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein.用嵌合VP4或VP6蛋白经鼻内免疫刺激小鼠产生的针对轮状病毒感染的非抗体依赖性保护作用。
J Virol. 1999 Sep;73(9):7574-81. doi: 10.1128/JVI.73.9.7574-7581.1999.

引用本文的文献

1
Expressing Murine Rotavirus VP8 and Mucosal Adjuvants Induce Virus-Specific Immune Responses.表达小鼠轮状病毒VP8和黏膜佐剂可诱导病毒特异性免疫反应。
Vaccines (Basel). 2023 Nov 28;11(12):1774. doi: 10.3390/vaccines11121774.
2
Recombinant lactic acid bacteria as promising vectors for mucosal vaccination.重组乳酸菌作为黏膜疫苗的理想载体
Exploration (Beijing). 2021 Oct 30;1(2):20210026. doi: 10.1002/EXP.20210026. eCollection 2021 Oct.
3
Rotavirus Infection in Swine: Genotypic Diversity, Immune Responses, and Role of Gut Microbiome in Rotavirus Immunity.

本文引用的文献

1
Mucosal delivery of vaccines in domestic animals.家畜疫苗的黏膜给药
Vet Res. 2006 May-Jun;37(3):487-510. doi: 10.1051/vetres:2006012. Epub 2006 Apr 14.
2
Evaluation of the Lon-deficient Salmonella strain as an oral vaccine candidate.评估Lon缺陷型沙门氏菌菌株作为口服疫苗候选物的情况。
Microbiol Immunol. 2005;49(12):1035-45. doi: 10.1111/j.1348-0421.2005.tb03700.x.
3
Intragastric administration of Lactobacillus casei expressing transmissible gastroentritis coronavirus spike glycoprotein induced specific antibody production.
猪轮状病毒感染:基因多样性、免疫反应及肠道微生物群在轮状病毒免疫中的作用
Pathogens. 2022 Sep 22;11(10):1078. doi: 10.3390/pathogens11101078.
4
Auxotrophic Expressing Porcine Rotavirus VP4 Constructed Using CRISPR-Cas9D10A System Induces Effective Immunity in Mice.利用CRISPR-Cas9D10A系统构建的营养缺陷型表达猪轮状病毒VP4在小鼠中诱导有效免疫。
Vaccines (Basel). 2022 Sep 9;10(9):1510. doi: 10.3390/vaccines10091510.
5
Evaluation of the immunogenicity of auxotrophic with CRISPR-Cas9D10A system-mediated chromosomal editing to express porcine rotavirus capsid protein .评价 CRISPR-Cas9D10A 系统介导的染色体编辑表达猪轮状病毒衣壳蛋白的缺陷型 的免疫原性 。
Virulence. 2022 Dec;13(1):1315-1330. doi: 10.1080/21505594.2022.2107646.
6
Construction of the Enterococcal Strain Expressing Immunogenic Fragment of SARS-Cov-2 Virus.表达新冠病毒免疫原性片段的肠球菌菌株构建
Front Pharmacol. 2022 Jan 5;12:807256. doi: 10.3389/fphar.2021.807256. eCollection 2021.
7
Immunogenicity of Recombinant-Deficient with Complementary Plasmid Expressing Alanine Racemase Gene and Core Neutralizing Epitope Antigen against Porcine Epidemic Diarrhea Virus.携带表达丙氨酸消旋酶基因和核心中和表位抗原的互补质粒的重组缺陷型对猪流行性腹泻病毒的免疫原性
Vaccines (Basel). 2021 Sep 26;9(10):1084. doi: 10.3390/vaccines9101084.
8
Probiotic-Based Vaccines May Provide Effective Protection against COVID-19 Acute Respiratory Disease.基于益生菌的疫苗可能为预防新冠急性呼吸道疾病提供有效保护。
Vaccines (Basel). 2021 May 6;9(5):466. doi: 10.3390/vaccines9050466.
9
Combined use of lactic-acid-producing bacteria as probiotics and rotavirus vaccine candidates expressing virus-specific proteins.联合使用产乳酸细菌作为益生菌和表达病毒特异性蛋白的轮状病毒候选疫苗。
Arch Virol. 2021 Apr;166(4):995-1006. doi: 10.1007/s00705-021-04964-9. Epub 2021 Feb 3.
10
Immunomodulatory Properties of Bacterium-Like Particles Obtained From Immunobiotic Lactobacilli: Prospects for Their Use as Mucosal Adjuvants.免疫生物性乳杆菌来源的菌样颗粒的免疫调节特性:作为黏膜佐剂的应用前景。
Front Immunol. 2020 Jan 23;11:15. doi: 10.3389/fimmu.2020.00015. eCollection 2020.
口服表达传染性胃肠炎冠状病毒刺突糖蛋白的干酪乳杆菌可诱导特异性抗体产生。
Vaccine. 2005 Feb 3;23(11):1335-42. doi: 10.1016/j.vaccine.2004.09.015.
4
Vaccine-induced protection against gastrointestinal bacterial infections in the absence of secretory antibodies.在缺乏分泌性抗体的情况下,疫苗诱导的针对胃肠道细菌感染的保护作用。
Eur J Immunol. 2005 Jan;35(1):180-8. doi: 10.1002/eji.200425492.
5
Mucosal vaccine made from live, recombinant Lactococcus lactis protects mice against pharyngeal infection with Streptococcus pyogenes.由活的重组乳酸乳球菌制成的黏膜疫苗可保护小鼠免受化脓性链球菌的咽部感染。
Infect Immun. 2004 Jun;72(6):3444-50. doi: 10.1128/IAI.72.6.3444-3450.2004.
6
Permanent colonization by Lactobacillus casei is hindered by the low rate of cell division in mouse gut.干酪乳杆菌在小鼠肠道中的永久定殖受到其在小鼠肠道中细胞分裂速率较低的阻碍。
Appl Environ Microbiol. 2004 Feb;70(2):670-4. doi: 10.1128/AEM.70.2.670-674.2004.
7
Mice immunization with live lactococci displaying a surface anchored HPV-16 E7 oncoprotein.用展示表面锚定的人乳头瘤病毒16型E7癌蛋白的活乳酸乳球菌对小鼠进行免疫接种。
FEMS Microbiol Lett. 2003 Dec 5;229(1):37-42. doi: 10.1016/S0378-1097(03)00778-X.
8
Expression of Streptococcus pneumoniae antigens, PsaA (pneumococcal surface antigen A) and PspA (pneumococcal surface protein A) by Lactobacillus casei.干酪乳杆菌对肺炎链球菌抗原PsaA(肺炎球菌表面抗原A)和PspA(肺炎球菌表面蛋白A)的表达
FEMS Microbiol Lett. 2003 Oct 10;227(1):25-31. doi: 10.1016/S0378-1097(03)00645-1.
9
Immunogenicity and protective efficacy of orally administered recombinant Lactococcus lactis expressing surface-bound HIV Env.口服表达表面结合型HIV Env的重组乳酸乳球菌的免疫原性和保护效力
Blood. 2003 Jul 1;102(1):223-8. doi: 10.1182/blood-2003-01-0110. Epub 2003 Mar 20.
10
Intestinal IgA synthesis: regulation of front-line body defences.肠道IgA合成:一线身体防御的调节
Nat Rev Immunol. 2003 Jan;3(1):63-72. doi: 10.1038/nri982.